Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability
Sign Up to like & getrecommendations! Published in 2022 at "Antibodies"
DOI: 10.3390/antib11010006
Abstract: The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase whose proliferative effects can contribute to the development of many types of solid tumors when overexpressed. For this reason, EGFR inhibitors such as cetuximab… read more here.
Keywords: egfr engager; engineering enhanced; cetuximab; enhanced egfr ... See more keywords